Announcement

Collapse
No announcement yet.

Gut. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Gut. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic


    Gut. 2020 Apr 17. pii: gutjnl-2020-321244. doi: 10.1136/gutjnl-2020-321244. [Epub ahead of print]
    British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.


    Kennedy NA1,2, Jones GR3,4, Lamb CA5,6, Appleby R7, Arnott I4, Beattie RM8, Bloom S9, Brooks AJ10, Cooney R11,12, Dart RJ13,14, Edwards C15, Fraser A16, Gaya DR17,18, Ghosh S11,12, Greveson K14, Hansen R18,19, Hart A20,21, Hawthorne AB22, Hayee B13,23, Limdi JK24,25, Murray CD14, Parkes GC26,27, Parkes M28, Patel K29, Pollok RC29,30, Powell N21,31, Probert CS32,33, Raine T28, Sebastian S34, Selinger C35, Smith PJ32, Stansfield C36, Younge L37, Lindsay JO26,27, Irving PM13,38, Lees CW39,4.

    Author information




    Abstract

    The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.
    ? Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.



    KEYWORDS:

    crohn's colitis; crohn's disease; ulcerative colitis


    PMID:32303607DOI:10.1136/gutjnl-2020-321244
Working...
X